Ads
related to: moderna vaccine update
Search results
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 3 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 3 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
Why Moderna Stock Is Sinking This Week
Motley Fool via Yahoo Finance· 3 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider this: The Motley Fool...Advisor provides investors with an...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 3 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 6 days agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Colorado Springs Gazette· 4 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 5 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 3 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA ...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 5 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines</ ...